Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Supervisor: Prof Kazem Rahimi

Co-supervisors: Dr Dexter Canoy, Dr Abbas Dehghan, Dr Derrick Bennett


Blood pressure lowering is an established strategy for preventing microvascular and macrovascular complications of diabetes, but its role in the prevention of diabetes itself is unclear. Additionally, controversy exists as to whether the threshold for blood pressure-lowering treatment should differ between people with and without type 2 diabetes. In this project, we integrated randomised clinical trials and genetic data to provide robust answers to these questions.